- Home
- AKRO vs STNE Comparison
AKRO vs STNE Comparison
Compare AKRO & STNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- STNE
- Stock Information
- Founded
- AKRO 2017
- STNE 2012
- Country
- AKRO United States
- STNE Cayman Islands
- Employees
- AKRO N/A
- STNE N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- STNE EDP Services
- Sector
- AKRO Health Care
- STNE Technology
- Exchange
- AKRO Nasdaq
- STNE Nasdaq
- Market Cap
- AKRO 3.6B
- STNE 4.0B
- IPO Year
- AKRO 2019
- STNE 2018
- Fundamental
- Price
- AKRO $46.27
- STNE $19.09
- Analyst Decision
- AKRO Strong Buy
- STNE Buy
- Analyst Count
- AKRO 8
- STNE 8
- Target Price
- AKRO $80.38
- STNE $16.56
- AVG Volume (30 Days)
- AKRO 915.6K
- STNE 4.5M
- Earning Date
- AKRO 11-07-2025
- STNE 11-11-2025
- Dividend Yield
- AKRO N/A
- STNE N/A
- EPS Growth
- AKRO N/A
- STNE N/A
- EPS
- AKRO N/A
- STNE N/A
- Revenue
- AKRO N/A
- STNE $2,526,103,178.00
- Revenue This Year
- AKRO N/A
- STNE $21.73
- Revenue Next Year
- AKRO N/A
- STNE $6.95
- P/E Ratio
- AKRO N/A
- STNE N/A
- Revenue Growth
- AKRO N/A
- STNE 19.78
- 52 Week Low
- AKRO $21.34
- STNE $7.72
- 52 Week High
- AKRO $58.40
- STNE $19.39
- Technical
- Relative Strength Index (RSI)
- AKRO 51.29
- STNE 79.93
- Support Level
- AKRO $41.80
- STNE $15.96
- Resistance Level
- AKRO $45.44
- STNE $19.39
- Average True Range (ATR)
- AKRO 1.97
- STNE 0.52
- MACD
- AKRO 0.06
- STNE 0.17
- Stochastic Oscillator
- AKRO 75.76
- STNE 91.11
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About STNE StoneCo Ltd.
StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.